In the last 30 years, Research on the effects cannabis on the human body led to the discovery of the ECS, or endocannabinoid system. CBD is a cannabinoid. The ECS is a complex system of cannabinoid receptors found throughout the body, but mainly in the immune and nervous systems. The ECS plays a role in communicating with, and regulating virtually every system and organ in the body. A healthy ECS enables Homeostasis, which is when our cells, organs, and physiological systems are in balance and working properly. CBD works extremely efficiently with the ECS to help maintain that homeostasis and balance across the different systems of our body. CBD helps the body heal and balance itself*.
CBD Dosage for Anxiety
Behind pain, anxiety might be the most common use for CBD. In addition to its physically relieving effects, it can also relax you mentally*. This can help with anxiety, depression, and stress in general for many users*.
LEARN WHY PEOPLE ARE CHOOSING CBD OVER PHARMACEUTICAL MEDICINES.
If you find that your initial CBD dosage isn’t working, you can always increase it. Taking CBD in higher dosages won’t harm your health or cause side effects as THC and other medications might. You may also want to consult with a doctor if you’re unsure on how much to take for your specific condition.
Studies generally indicate that a dosage of around 15-25mg of CBD per day is best. Those with a higher body weight may need more per day. It can also depend on the severity of your symptoms. For instance, those suffering from severe chronic pain will likely need more than those with aches and strains.
CBD is a popular and effective treatment for many medical conditions and symptoms. It can help with chronic pain, anxiety, depression, seizures, and even cancer*. Even for those not suffering from any medical ailments, CBD can be used to lower stress, improve sleep, and prevent the risk of various illnesses*. When it comes to CBD dosages, how much to take can vary depending on what you’re using it for.
To smooth the regulatory pathway, the DEA has recently stated, " DEA anticipates that additional strains of marihuana will be produced and made available to researchers. This should facilitate research, advance scientific understanding about the effects of marihuana, and potentially aid in the development of safe and effective drug products that may be approved for marketing by the Food and Drug Administration.
ST. PETERSBURG, FL / ACCESSWIRE / March 10, 2021 / MMJ International Holdings, the premier medical cannabis research company, announced that it is completing the FDA required manufacturing of its proprietary THC and CBD gel cap medicine. MMJ International Holdings is developing a non-synthetic oral drug product from the marijuana plant extracts. MMJ will be utilizing its new product for an FDA-approved treatment of multiple sclerosis (MS), and Huntington's disease (HD) for its clinical trials once approved.
"As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company has supported MMJ with the FDA, DEA required development for its specialized liquid encapsulation manufacturing," said Elio Mariani, Ph.D., in charge of research & development. "Patients will benefit from cGMP-quality therapies in an accessible and efficient format. We firmly believe that our MMJ oral gel cap medication, containing the marijuana plant's unique pharmacological properties, will be FDA-approved as a safe and effective drug," he further stated.
MMJ International Holdings has executed a supply agreement with MMJ BioPharma Cultivation, who's has filed an application with the DEA for a "Bulk Manufacturing Permit."The DEA is currently processing the company's application so it can proceed with the FDA-required evaluation and research.
Tim Moynahan, MMJIH chairman, mentioned, "We recognize that there is significant public interest in cannabis and cannabis-derived compounds; however, we must work with the FDA And DEA to fill in the knowledge gaps about the science safety and quality of MMJ's products. We are committed to advancing our product development through an approach that is in line with our mission to prioritizes public health, fosters innovation, and promotes consumer confidence."
Medical Cannabis Registration Applications for Patients, Parents/Legal Guardians, Registered Agents and Practitioners
New video from the Board of Pharmacy – So You Know | CBD vs Hemp.
Request for Application
Before a practitioner can issue or continue issuing written certifications, he or she must register with the Board of Pharmacy. Learn More about Practitioner Registration.
A patient, parent, legal guardian or registered agent may possess medical cannabis, as defined in §54.1-3408.3 of the Code of Virginia who has been issued a valid written certification from a Board of Pharmacy-registered practitioner and who maintains a current registration with the Board of Pharmacy.
A patient, or the patient’s parent or legal guardian, may chose a registered agent to receive medical cannabis on behalf of the patient. . Learn More about Registered Agent Registration.